Background The prognostic-related factors of lung invasive mucinous adenocarcinoma
(IMA) are unclear because of its rarity. Various inflammation-based biomarkers were …

Background Immune function is a key component affecting tumor progression in patients
with cancer. The purpose of this study was to identify the prognostic value of systemic …

Background The systemic immune‐inflammation index (SII) is correlated with patient
survival in various types of solid tumors. However, only a few studies have focused on the …

Background: The systemic immune-inflammation index (SII) is reported to be associated with
clinical outcomes and has been proven to be a promising prognostic indicator in several …

Background A novel systemic immune-inflammation index (SII) has been recently reported
to be associated with clinical outcome in several tumors. However, the prognostic value of …

Background The relationship between systemic immune inflammation index (SII) and the
prognosis of cancer has always been a subject of intense interest. However, the prognostic …

Background Lung invasive mucinous adenocarcinoma (LIMA) is a unique and rare subtype
of lung adenocarcinoma. We identified prognostic factors and developed a nomogram for …

Background Lung cancer remains the leading cause of cancer death globally. In 2015, the
cancer classification guidelines of the World Health Organization were updated. The term …

Background Invasive mucinous adenocarcinoma (IMA) of the lung is a rare and distinct
subtype of adenocarcinoma. At present, people have no idea whether IMA patients can …

Objectives: The purpose of the present study was to evaluate the prognostic value of a
systemic immune-inflammation index (SII) and the relationship between SII and the …